Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Smolle (Graz, Austria), T. Roeblreiter (Graz, Austria), H. Flick (Graz, Austria). Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved.. 4502

Member's Comments

No comment yet.

Related content which might interest you: Factors affecting attitude towards pneumococcal and influenza vaccination in patients admitting to a pulmonary diseases outpatient clinic Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Outcome of influenza vaccination in elderly with pneumonia Source: International Congress 2019 – Airway infection in COPD Year: 2019 Pneumococcal and influenza vaccine uptake in patients discharged from an acute medical hospital Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives Year: 2008 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Clinical diagnosis of influenza infection in children Source: Eur Respir J 2002; 20: Suppl. 38, 336s Year: 2002 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Influenza A/H1N1 infection in hospitalized patients in ward and ICU Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Effectiveness of a protocolized care intervention for adults with pneumonia associated with pandemic H1N1 virus Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011 Should pneumococcal vaccines be used to prevent LRTI? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Compliance with the pneumococcal and influenza vaccination recommendations in patients with COPD in Catalonia (Spain) Source: Eur Respir J 2005; 26: Suppl. 49, 594s Year: 2005 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Influenza vaccination is associated with reduced severity of community-acquired pneumonia Source: Eur Respir J 2011; 37: 147-153 Year: 2011 Clinical effectiveness of pneumococcal vaccination against nonbacteremic pneumonia in people over 50 years Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Influenza vaccination in chronic asthma patients. Are more severely ill patients more likely to seek vaccination? Source: Annual Congress 2013 –Viral infections Year: 2013